Veru, Inc. (VERU)
2.61
-0.03
(-1.14%)
USD |
NASDAQ |
Aug 24, 16:00
2.61
0.00 (0.00%)
After-Hours: 20:00
Veru Enterprise Value : 21.90M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 21.90M |
| August 20, 2026 | 20.88M |
| August 19, 2026 | 21.90M |
| August 18, 2026 | 21.05M |
| August 17, 2026 | 21.73M |
| August 14, 2026 | 23.44M |
| August 13, 2026 | 22.93M |
| August 12, 2026 | 23.61M |
| August 11, 2026 | 24.46M |
| August 10, 2026 | 24.12M |
| August 07, 2026 | 16.62M |
| August 06, 2026 | 16.28M |
| August 05, 2026 | 16.62M |
| August 04, 2026 | 17.30M |
| August 03, 2026 | 15.43M |
| July 31, 2026 | 15.08M |
| July 30, 2026 | 14.74M |
| July 29, 2026 | 14.57M |
| July 28, 2026 | 14.91M |
| July 27, 2026 | 15.77M |
| July 24, 2026 | 15.25M |
| July 23, 2026 | 16.28M |
| July 22, 2026 | 15.43M |
| July 21, 2026 | 16.79M |
| July 20, 2026 | 16.11M |
| Date | Value |
|---|---|
| July 17, 2026 | 17.47M |
| July 16, 2026 | 16.96M |
| July 15, 2026 | 18.15M |
| July 14, 2026 | 16.28M |
| July 13, 2026 | 20.54M |
| July 10, 2026 | 24.29M |
| July 09, 2026 | 24.80M |
| July 08, 2026 | 22.25M |
| July 07, 2026 | 26.00M |
| July 06, 2026 | 25.14M |
| July 02, 2026 | 29.07M |
| July 01, 2026 | 30.77M |
| June 30, 2026 | 30.26M |
| June 29, 2026 | 22.15M |
| June 26, 2026 | 20.38M |
| June 25, 2026 | 19.26M |
| June 24, 2026 | 19.74M |
| June 23, 2026 | 20.86M |
| June 22, 2026 | 19.58M |
| June 18, 2026 | 19.42M |
| June 17, 2026 | 20.06M |
| June 16, 2026 | 22.31M |
| June 15, 2026 | 22.31M |
| June 12, 2026 | 20.22M |
| June 11, 2026 | 24.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.966B |
| Corcept Therapeutics, Inc. | 12.89B |
| Johnson & Johnson | 679.08B |
| Eli Lilly & Co. | 1.228T |
| Lexicon Pharmaceuticals, Inc. | 891.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.988M |
| Total Expenses (Quarterly) | 6.988M |
| EPS Diluted (Quarterly) | -0.3032 |
| Earnings Yield | -23.41% |
| Normalized Earnings Yield | -28.50 |